Literature DB >> 7231687

Studies of intravascular components in cerebral vasospasm following subarachnoid hemorrhage.

T Hasegawa, H Watanabe, S Ishii.   

Abstract

Cerebral vasospasm with subsequent infarction gives important influence to the prognosis of patients with ruptured intracranial aneurysms. Many factors should be considered in the pathogenesis of cerebral infraction. Clinical and experimental studies of intravascular components with particular reference to platelet and coagulation factors were performed. Both studies revealed systemic platelet hyperactivity and a hypercoagulable state; in further experimental studies, crenated red blood cells were recognized in the course of cerebral vasospasm. These systemic changes of intravascular components are thought to accelerate cerebral ischemia through formation of microthrombosis, increased blood viscosity and reduced deformability of the red blood cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7231687     DOI: 10.1007/bf01644061

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  33 in total

1.  Adenosine triphosphate and shape of erythrocytes.

Authors:  M NAKAO; T NAKAO; S YAMAZOE; H YOSHIKAWA
Journal:  J Biochem       Date:  1961-06       Impact factor: 3.387

2.  Present status of spiculed red cells and their relationship to the discocyte-echinocyte transformation: a critical review.

Authors:  G Brecher; M Bessis
Journal:  Blood       Date:  1972-09       Impact factor: 22.113

3.  An assessment of early platelet activity in experimental subarachnoid hemorrhage and middle cerebral artery thrombosis in the cat.

Authors:  I C Denton; J T Robertson; M Dugdale
Journal:  Stroke       Date:  1971 May-Jun       Impact factor: 7.914

4.  Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.

Authors:  H Watanabe; M Ito; H Chigasaki; S Ishii
Journal:  Neurol Med Chir (Tokyo)       Date:  1976       Impact factor: 1.742

5.  [The role of platelets and erythrocytes in disturbance of cerebral microcirculation (author's transl)].

Authors:  S Kim; K Sano
Journal:  Neurol Med Chir (Tokyo)       Date:  1977-03       Impact factor: 1.742

6.  Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. An experimental study.

Authors:  Y Tanabe; K Sakata; H Yamada; T Ito; M Takada
Journal:  J Neurosurg       Date:  1978-08       Impact factor: 5.115

7.  Cerebral arterial spasm. Part 5: in vitro contractile activity of vasoactive agents including human CSF on human basilar and anterior cerebral arteries.

Authors:  G S Allen; C J Gross; L A French; S N Chou
Journal:  J Neurosurg       Date:  1976-05       Impact factor: 5.115

8.  Time course of vasospasm in man.

Authors:  B Weir; M Grace; J Hansen; C Rothberg
Journal:  J Neurosurg       Date:  1978-02       Impact factor: 5.115

9.  [Studies on the fibrinolytic system in ruptured intracranial aneurysm.--Part 2: Fibrinogen changes in acute stage of SAH as a risk factor of the ischemic complications following vasospasm (author's transl)].

Authors:  H Watanabe; S Ishii; T Matsuda
Journal:  No Shinkei Geka       Date:  1978-06

10.  [Studies on the fibrinolytic system in ruptured intracranial aneurysm. Part 1. Monitoring of the antifibrinolytic therapy through repeated measurement of SK-euglobulin lysis time and FDP (author's transl)].

Authors:  H Watanabe; H Chigasaki; S Ishii
Journal:  No Shinkei Geka       Date:  1977-07
View more
  2 in total

1.  Ultrastructural changes of the basilar artery following experimental subarachnoid haemorrhage. A morphological study on the pathogenesis of delayed cerebral vasospasm.

Authors:  V Seifert; D Stolke; E Reale
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

Review 2.  Microvascular platelet aggregation and thrombosis after subarachnoid hemorrhage: A review and synthesis.

Authors:  Julian V Clarke; Julia M Suggs; Deepti Diwan; Jin V Lee; Kim Lipsey; Ananth K Vellimana; Gregory J Zipfel
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-28       Impact factor: 6.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.